GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Polaris AI Pharma Corp (XKRX:041910) » Definitions » Institutional Ownership

Polaris AI Pharma (XKRX:041910) Institutional Ownership : 0.24% (As of Jan. 18, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Polaris AI Pharma Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Polaris AI Pharma's institutional ownership is 0.24%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Polaris AI Pharma's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Polaris AI Pharma's Float Percentage Of Total Shares Outstanding is 0.00%.


Polaris AI Pharma Institutional Ownership Historical Data

The historical data trend for Polaris AI Pharma's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polaris AI Pharma Institutional Ownership Chart

Polaris AI Pharma Historical Data

The historical data trend for Polaris AI Pharma can be seen below:

2024-02-29 2024-03-31 2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-12-31
Institutional Ownership 0.51 0.45 0.56 0.54 0.65 0.56 0.42 0.35 0.28 0.24

Polaris AI Pharma Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Polaris AI Pharma Business Description

Traded in Other Exchanges
N/A
Address
25 Balangongdan-ro, Hyangnam-eup, Gyeonggi-do, Hwaseong-si, KOR
Polaris AI Pharma Corp is engaged in the production of raw pharmaceutical ingredients. It focuses on generic drugs and produces about 40 types of raw medicines, including asthma treatments, gastric ulcer treatments, and alcohol dependence treatments, and supplies them domestically and internationally.

Polaris AI Pharma Headlines

No Headlines